Jorge Monserrat is a Professor in the Laboratory of Immune System Diseases and Oncology, Department of Medicine and Medical Specialties, University of Alcalá. The research lines of his group are (1) individualized translational medicine in inflammation and cancer; (2) characterization of intestinal dysbiosis and bacterial translocation in chronic autoimmune diseases, neuroinflammatory pathology, and cirrhosis; (3) characterization of the pathogenic mechanisms of the immune system, diagnostic and prognostic individualization, and therapeutic innovation in spinal cord injury; (4) venous aging and development of placental hypoxia; (5) identification of Dido and mutations in cancer. Study of Dido expression in pancreatic cancer and possible use as a biomarker of response; (6) therapeutic innovation in spinal cord injury; (7) hypoxia as a mechanism of action of the inflammation and cancer regulator PIK3R2; (8) role of Dido3 in cellular reprogramming and regeneration; (9) tissue regeneration in ulcerative complications of chronic venous insufficiency; and (10) regulation of autoimmune diseases by growth hormone: study in animal models of rheumatoid arthritis and multiple sclerosis, etc.